{"id":"W1964785646","doi":"10.1053/j.gastro.2005.06.064","title":"A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease","year":2005,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":581,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; Hôpital Saint-Luc; Dalhousie University; University of Alberta","funders":"","keywords":"Certolizumab pegol; Placebo; Medicine; Crohn's disease; Internal medicine; Gastroenterology; Clinical endpoint; Adverse effect; Clinical trial; Tumor necrosis factor alpha; Disease; Infliximab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001297963,0.0002351513,0.0008405945,0.00008160048,0.00003305938,0.0000044878,0.0001647092,0.0001042969,0.00004758775],"category_scores_gemma":[0.0002157747,0.0001927737,0.0008038926,0.0000168764,0.00023898,0.000004012368,0.00004059427,0.00002160288,0.000003411076],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003019216,"about_ca_system_score_gemma":0.0001192765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005385552,"about_ca_topic_score_gemma":0.00006740214,"domain_scores_codex":[0.9982195,0.0003256711,0.0006647864,0.0003297919,0.0001089726,0.0003512863],"domain_scores_gemma":[0.9988543,0.00006067047,0.0003683338,0.0004323985,0.0001248675,0.0001594725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9946224,0.0008919937,0.0009124688,0.00003699127,0.0004856981,0.00004226806,0.00004736169,0.0001559902,0.002107403,0.00007849149,0.0002444064,0.0003745049],"study_design_scores_gemma":[0.9934286,0.002086957,0.00157947,0.000006246558,0.0004334291,0.00001560983,0.00001077266,0.000548169,0.001151231,0.00004628591,0.0006032673,0.00008988965],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932659,0.0001258446,0.001467063,0.0003926439,0.0002131668,0.004264608,0.0001430712,0.000009739108,0.0001179301],"genre_scores_gemma":[0.9964871,0.0000723917,0.0005725098,0.00007046949,0.0004189552,0.001860415,0.0001185037,0.00002650251,0.0003731414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003221179,"threshold_uncertainty_score":0.7861085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008893918375164978,"score_gpt":0.2538233828180657,"score_spread":0.2449294644429007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}